approval for Moderna vax

US FDA delays approval for Moderna vax for teens

US drugmaker Moderna has confirmed that the Food and Drug Administration (FDA) has delayed granting the emergency use authorisation (EUA) to its Covid vaccine for teenagers aged 12 to 17, over the risk of myocarditis -- inflammation of the heart...